Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,892
Total Claims
$899K
Drug Cost
698
Beneficiaries
$1,288
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+36%
Opioid rate vs peers
3.0% vs 2.2% avg
-9%
Cost per patient vs peers
$1,288 vs $1,411 avg
+8%
Brand preference vs peers
11.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.0%
Opioid Rate
301
Opioid Claims
$8,001
Opioid Cost
10.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,130 claims · $712K
Generic: 8,686 claims · $184K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 101 | $106K |
| Dulaglutide | 54 | $86K |
| Insulin Glargine,hum.Rec.Anlog | 76 | $42K |
| Rivaroxaban | 30 | $33K |
| Mirabegron | 23 | $31K |
| Insulin Aspart | 22 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $25K |
| Insulin Aspart | 38 | $25K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $24K |
| Empagliflozin | 19 | $20K |
| Fluticasone/Umeclidin/Vilanter | 21 | $20K |
| Semaglutide | 18 | $18K |
| Insulin Degludec | 11 | $15K |
| Insulin Lispro | 15 | $15K |
| Semaglutide | 15 | $14K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About